Relationship Between Women's Libido Disorders According To The DSDS (Decreased Sexual Desire Screener) Questionnaire With Saliva Testosterone Levels In Surgical Menopause

by ADMIN 171 views

The Relationship between Women's Libido Disorders According to the DSDS Questionnaire with Saliva Testosterone levels in Surgical Menopause

Introduction

Hormonal changes in a woman's life can have a significant impact on various aspects of health, including libido. The decrease in estrogen levels during menopause can lead to a range of symptoms, including vaginal dryness, hot flashes, and decreased libido. However, the relationship between testosterone levels and libido disorders in women who experience surgical menopause is not well understood. This study aims to investigate the relationship between testosterone levels in saliva and libido disorders in women who have undergone surgical menopause.

Background

Surgical menopause, also known as induced menopause, occurs when a woman undergoes a surgical procedure that removes her ovaries, leading to a sudden drop in estrogen levels. This can result in a range of symptoms, including hot flashes, vaginal dryness, and decreased libido. Testosterone, a hormone often associated with men, also plays an important role in women's sexual health. Research has shown that testosterone levels decline with age, and this decline is associated with decreased libido in women.

Methodology

This study used a case-control design, with 54 women participating in the study. The participants were divided into two groups: 27 women who had undergone surgical menopause and 27 women who had not. The women who had undergone surgical menopause were examined for FSH hormone levels in the blood, while testosterone levels were measured using salivary samples. The women were also administered the Decreased Sexual Desire Screener (DSDS) questionnaire to evaluate libido disorders.

Results

The results of the study showed that the average FSH levels in the group of surgical menopause women reached 59.29 miu/ml with a standard deviation of 15.15 miu/ml. The average testosterone level in this group was 22.41 pg/ml, while in the control group, testosterone levels reached 44.22 pg/ml, with a p value <0.001. Of the 27 women who experienced surgical menopause, as many as 20 people (74.1%) experienced libido disorders, while in the control group, only 5 people (18.5%) reported similar problems. These results indicate that women with surgical menopause have a risk of 12,571 times higher experiencing libido disorders compared to the control group.

Discussion

The results of this study highlight the importance of testosterone levels in influencing female libido, especially in those who have undergone surgical menopause. Low levels of hormones, as seen in the group of female menopause, can contribute to a decrease in sexual desire. Testosterone, although often associated with men, also plays an important role in women's sexual health. The study also suggests that significant libido disorders in surgery menopause may be caused by a combination of hormonal changes, psychological conditions, and other physiological factors related to the aging process.

Conclusion

In conclusion, this study found a significant relationship between testosterone levels in saliva and libido disorders in women who experience surgical menopause. The results of this study have important implications for the management of female reproductive health, particularly in the context of menopause. It is essential to provide a more holistic approach to managing female reproductive health, including hormonal health management, to help women overcome problems related to their post-menopausal libido.

Recommendations

Based on the findings of this study, the following recommendations are made:

  1. Hormonal health management: Women who experience surgical menopause should be provided with hormonal health management to help regulate their hormone levels and alleviate symptoms of menopause.
  2. Testosterone replacement therapy: Testosterone replacement therapy may be beneficial for women who experience low testosterone levels and libido disorders.
  3. Counseling and education: Women who experience surgical menopause should be provided with counseling and education on the management of their reproductive health, including hormonal health management and testosterone replacement therapy.
  4. Further research: Further research is needed to investigate the relationship between testosterone levels and libido disorders in women who experience surgical menopause.

Limitations

This study has several limitations, including:

  1. Small sample size: The sample size of this study was small, which may limit the generalizability of the findings.
  2. Selection bias: The study may be subject to selection bias, as the participants were selected based on their willingness to participate in the study.
  3. Measurement bias: The study may be subject to measurement bias, as the testosterone levels were measured using salivary samples.

Future Directions

Future studies should aim to investigate the relationship between testosterone levels and libido disorders in women who experience surgical menopause in a larger and more diverse sample. Additionally, further research is needed to investigate the effectiveness of hormonal health management and testosterone replacement therapy in alleviating symptoms of menopause.
Frequently Asked Questions (FAQs) about the Relationship between Women's Libido Disorders and Saliva Testosterone levels in Surgical Menopause

Q: What is surgical menopause?

A: Surgical menopause, also known as induced menopause, occurs when a woman undergoes a surgical procedure that removes her ovaries, leading to a sudden drop in estrogen levels.

Q: What is the relationship between testosterone levels and libido disorders in women who experience surgical menopause?

A: The results of this study showed that there is a significant relationship between testosterone levels in saliva and libido disorders in women who experience surgical menopause. Women with surgical menopause have a risk of 12,571 times higher experiencing libido disorders compared to the control group.

Q: What are the symptoms of menopause?

A: The symptoms of menopause can include hot flashes, vaginal dryness, decreased libido, and mood changes.

Q: What is the Decreased Sexual Desire Screener (DSDS) questionnaire?

A: The DSDS questionnaire is a tool used to evaluate libido disorders in women. It is a self-report questionnaire that assesses the frequency and severity of sexual desire and arousal.

Q: What is testosterone replacement therapy?

A: Testosterone replacement therapy is a treatment that involves administering testosterone to women who have low testosterone levels. It is often used to treat symptoms of low testosterone, such as decreased libido and fatigue.

Q: Can testosterone replacement therapy help alleviate symptoms of menopause?

A: Yes, testosterone replacement therapy may be beneficial for women who experience low testosterone levels and symptoms of menopause, such as decreased libido and vaginal dryness.

Q: What are the risks and benefits of testosterone replacement therapy?

A: The risks and benefits of testosterone replacement therapy are not fully understood and require further research. However, potential benefits include improved libido and vaginal health, while potential risks include increased risk of blood clots and stroke.

Q: How can women manage their reproductive health during menopause?

A: Women can manage their reproductive health during menopause by:

  • Maintaining a healthy lifestyle, including a balanced diet and regular exercise
  • Getting regular check-ups with their healthcare provider
  • Considering hormone replacement therapy or testosterone replacement therapy
  • Engaging in counseling and education on menopause management

Q: What are the next steps for further research on the relationship between testosterone levels and libido disorders in women who experience surgical menopause?

A: Further research is needed to investigate the relationship between testosterone levels and libido disorders in women who experience surgical menopause. This may include larger and more diverse sample sizes, as well as more comprehensive assessments of libido disorders and testosterone levels.

Q: How can women who experience surgical menopause access resources and support for managing their reproductive health?

A: Women who experience surgical menopause can access resources and support for managing their reproductive health by:

  • Contacting their healthcare provider for guidance and support
  • Reaching out to local support groups for women who have undergone surgical menopause
  • Seeking counseling and education on menopause management
  • Considering hormone replacement therapy or testosterone replacement therapy under the guidance of a healthcare provider.